Deborah Schrag
Deborah Schrag
Harvard Medical School
بريد إلكتروني تم التحقق منه على dfci.harvard.edu
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population
JL Warren, CN Klabunde, D Schrag, PB Bach, GF Riley
Medical care, IV3-IV18, 2002
16502002
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson III, D Schrag, MR Somerfield, AM Cohen, AT Figueredo, ...
Journal of clinical oncology 22 (16), 3408-3419, 2004
13842004
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
KY Chung, J Shia, NE Kemeny, M Shah, GK Schwartz, A Tse, A Hamilton, ...
Journal of clinical oncology 23 (9), 1803-1810, 2005
12942005
Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment
BK Edwards, ML Brown, PA Wingo, HL Howe, E Ward, LAG Ries, ...
Journal of the National Cancer Institute 97 (19), 1407-1427, 2005
11512005
Patients' expectations about effects of chemotherapy for advanced cancer
JC Weeks, PJ Catalano, A Cronin, MD Finkelman, JW Mack, NL Keating, ...
New England Journal of Medicine 367 (17), 1616-1625, 2012
9312012
Primary care physicians who treat blacks and whites
PB Bach, HH Pham, D Schrag, RC Tate, JL Hargraves
New England Journal of Medicine 351 (6), 575-584, 2004
9232004
Primary care physicians who treat blacks and whites
PB Bach, HH Pham, D Schrag, RC Tate, JL Hargraves
New England Journal of Medicine 351 (6), 575-584, 2004
9232004
Variations in morbidity after radical prostatectomy
CB Begg, ER Riedel, PB Bach, MW Kattan, D Schrag, JL Warren, ...
New England Journal of Medicine 346 (15), 1138-1144, 2002
8722002
Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial
E Basch, AM Deal, MG Kris, HI Scher, CA Hudis, P Sabbatini, L Rogak, ...
Journal of Clinical Oncology 34 (6), 557, 2016
8112016
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303)
HL Kindler, D Niedzwiecki, D Hollis, S Sutherland, D Schrag, H Hurwitz, ...
Journal of Clinical Oncology 28 (22), 3617, 2010
7752010
How to build and interpret a nomogram for cancer prognosis
A Iasonos, D Schrag, GV Raj, KS Panageas
Journal of clinical oncology 26 (8), 1364-1370, 2008
7552008
American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options
LE Schnipper, NE Davidson, DS Wollins, C Tyne, DW Blayney, D Blum, ...
Journal of Clinical Oncology 33 (23), 2563, 2015
6712015
The influence of hospital volume on survival after resection for lung cancer
PB Bach, LD Cramer, D Schrag, RJ Downey, SE Gelfand, CB Begg
New England Journal of Medicine 345 (3), 181-188, 2001
6632001
Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
E Basch, AM Deal, AC Dueck, HI Scher, MG Kris, C Hudis, D Schrag
Jama 318 (2), 197-198, 2017
6242017
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience
SY Zafar, JM Peppercorn, D Schrag, DH Taylor, AM Goetzinger, X Zhong, ...
The oncologist 18 (4), 381, 2013
5712013
Care patterns in Medicare and their implications for pay for performance
HH Pham, D Schrag, AS O'Malley, B Wu, PB Bach
New England Journal of Medicine 356 (11), 1130-1139, 2007
5282007
Age and adjuvant chemotherapy use after surgery for stage III colon cancer
D Schrag, LD Cramer, PB Bach, CB Begg
Journal of the National Cancer Institute 93 (11), 850-857, 2001
5202001
Decision analysis—effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations
D Schrag, KM Kuntz, JE Garber, JC Weeks
New England Journal of Medicine 336 (20), 1465-1471, 1997
5181997
The price tag on progress—chemotherapy for colorectal cancer
D Schrag
New England Journal of Medicine 351 (4), 317-319, 2004
5142004
American Society of Clinical Oncology guidance statement: the cost of cancer care
NJ Meropol, D Schrag, TJ Smith, TM Mulvey, RM Langdon Jr, D Blum, ...
Journal of Clinical Oncology 27 (23), 3868-3874, 2009
5032009
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20